Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02203981 · ClinicalTrials.gov registry record
TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000
A clinical trial, sponsored by Topcon Medical Systems.
- Completed
- Registry status
- 12
- Enrollment target
NCT02203981: Completed study, sponsored by Topcon Medical Systems.
NCT02203981 is a clinical trial that has completed, run by Topcon Medical Systems. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02203981 has completed, sponsored by Topcon Medical Systems.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
To determine optimal cut-off value for the TopQ cut-off on the Maestro and 3D OCT-2000.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-08 |
What the finished NCT02203981 record still lists
NCT02203981 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02203981 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02203981 about?
NCT02203981 is a clinical study titled "TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000". To determine optimal cut-off value for the TopQ cut-off on the Maestro and 3D OCT-2000.
What is the current status of trial NCT02203981?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2014-01. Estimated completion is 2014-08.
Who is sponsoring clinical trial NCT02203981?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia